Closing the Gap: Improving Diagnosis in the U.S. Cystic Fibrosis Population

May 18 @ 12:30 pm 1:00 pm PDT

Innovation Theater 1: Booth 126
Supported By: Vertex Pharmaceuticals


Program Description

Although newborn screening has dramatically improved early diagnosis of cystic fibrosis (CF), diagnosis of CF can still be missed. This program will review CF prevalence and unique aspects of the diagnosis of CF across racial and ethnic groups and in adult patients, clinical symptoms that indicate the need for further evaluation, and the criteria used to establish the diagnosis of CF. In addition, we will review the impact of a delayed diagnosis on long-term patient outcomes. For the discussion section, Dr. Polineni will review a case study of CF diagnosis with the audience to highlight diagnostic challenges.

Speakers

Presenter: Dr. Deepika Polineni, MD, MPH
Washington University in St. Louis
Professor of Pediatrics and Medicine
St. Louis, Missouri